MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-10-2026
Sonoma Pharmaceuticals Long Term Debt Current 2011-2026 | SNOA
Annual Long Term Debt Current Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58 K | 198 K | 256 K | 250 K | 240 K | 251 K | 497 K | 230 K | 123 K | 114 K | 87 K | 143 K | 1.26 M | 1.42 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.42 M | 58 K | 366 K |
Long Term Debt Current of other stocks in the Drug manufacturers industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Assertio Holdings
ASRT
|
240 K | $ 18.03 | 0.06 % | $ 115 M |  USA |
 |
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
5.36 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
1.38 M | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
13.4 K | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
357 K | $ 3.26 | 5.5 % | $ 45.8 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
3.91 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M |  Canada |
 |
Bausch Health Companies
BHC
|
61 M | $ 5.64 | 0.45 % | $ 2.06 B | Canada |
 |
Harrow Health
HROW
|
887 K | $ 36.64 | 1.98 % | $ 1.35 B | USA |
 |
Aurora Cannabis
ACB
|
5.38 M | $ 3.36 | -2.04 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
7.46 M | $ 1.03 | -1.43 % | $ 111 M | Canada |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 1.4 | -0.36 % | $ 402 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
3.05 M | - | - | $ 193 M | Canada |
 |
Jupiter Wellness
JUPW
|
23.5 K | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
2.53 M | $ 4.35 | 1.76 % | $ 280 M | USA |
 |
Emergent BioSolutions
EBS
|
3.5 M | $ 8.0 | 0.5 % | $ 410 M | USA |
 |
Sundial Growers
SNDL
|
35.5 M | $ 1.37 | -3.87 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
2.47 M | $ 6.49 | -1.29 % | $ 4.01 B | Canada |
 |
Organogenesis Holdings
ORGO
|
4.27 M | $ 2.37 | -0.35 % | $ 312 M | USA |
 |
Pacira BioSciences
PCRX
|
8.89 M | $ 24.3 | 2.14 % | $ 1.12 B | USA |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
Veru
VERU
|
1.07 M | $ 2.42 | 1.68 % | $ 326 M | USA |
 |
Viatris
VTRS
|
80.6 M | $ 13.53 | 0.45 % | $ 16.2 B | USA |
 |
ProPhase Labs
PRPH
|
301 K | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
98.7 K | $ 0.7 | 4.36 % | $ 3.02 M | USA |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
911 K | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
483 K | $ 1.02 | 2.0 % | $ 50.9 M | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
2.1 M | $ 7.92 | -1.25 % | $ 693 M | USA |
 |
Zomedica Corp.
ZOM
|
717 K | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
1.16 M | $ 0.91 | 0.02 % | $ 32.7 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
71.6 K | $ 0.65 | 3.14 % | $ 2.79 M |  China |
 |
TherapeuticsMD
TXMD
|
975 K | $ 2.03 | -1.93 % | $ 23.5 M | USA |